Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Therapy areas
Gastroenterology
Gastroenterology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gastroenterology
Emmaus Life Sciences Reports Positive Top-Line Preliminary Results in First Patient in Diverticulosis Pilot TrialDecreased Size of Diverticula, Indications of Healing and Normalization of...
Biospace News
-
January 29, 2020
Gastroenterology
Tesamorelin Study Results on NAFLD Published in Lancet HIV
Gastroenterology
Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome
Gastroenterology
Genkyotex Announces Completion of 24-Week Treatment Period of Its Phase 2 Trial with GKT831 in Primary Biliary Cholangitis
Gastroenterology
Direct-Acting Antivirals for Treating Hepatitis C Virus Affect Incidence of New-Onset Diabetes: Presented at CROI
Gastroenterology
DURECT Corporation to Participate in the Berenberg NASH Day
Biospace News
-
February 21, 2019
0
Gastroenterology
Lipocine Inc. Announces FDA Clearance of IND to Commence Phase 2...
Biospace News
-
February 14, 2019
0
- Advertisement -
MOST POPULAR
Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets...
March 1, 2019
Roche’s $4.8 Billion Acquisition of Spark Pushed Back to April 2020
July 8, 2019
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial...
February 12, 2019
AI Therapeutics Announces Significant Progress on LAM-001 and LAM-004 Programs
January 7, 2020
Load more
HOT NEWS
Commercial
Palleon Pharmaceuticals Announces Successful Defense of European Patent
Deals
AstraZeneca sells rights to established hypertension medicines to Atnahs Pharma for...
Phase I
Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201...
Approval
Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed’s Oral Insulin...
